Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples